PetVivo Holdings Ausschüttungen und Rückkäufe

Zukünftiges Wachstum Kriterienprüfungen 0/6

PetVivo Holdings hat in der Vergangenheit keine Dividende gezahlt.

Wichtige Informationen

n/a

Dividendenausschüttung

-38.0%

Rückkaufsrendite

Gesamte Aktionärsrendite	-38.0%
Zukünftige Dividendenrendite	n/a
Wachstum der Dividende	n/a
Nächster Dividendenzahlungstermin	n/a
Ex-Dividendendatum	n/a
Dividende pro Aktie	n/a
Ausschüttungsquote	n/a

Jüngste Updates zu Dividenden und Rückkäufen

Keine Aktualisierungen

Recent updates

Companies Like PetVivo Holdings (NASDAQ:PETV) Could Be Quite Risky

Nov 11

Will PetVivo Holdings (NASDAQ:PETV) Spend Its Cash Wisely?

Jul 26

PetVivo Holdings GAAP EPS of -$0.57 beats by $0.37, revenue of $0.1M misses by $1.6M

Jun 29

We Think PetVivo Holdings (NASDAQ:PETV) Can Afford To Drive Business Growth

Mar 23

Stabilität und Wachstum des Zahlungsverkehrs

Rufe Dividendendaten ab

Stabile Dividende: Es liegen keine ausreichenden Daten vor, um festzustellen, ob die Dividende je Aktie von PETV in der Vergangenheit stabil war.

Wachsende Dividende: Unzureichende Daten, um festzustellen, ob die Dividendenzahlungen von PETV gestiegen sind.

Dividendenrendite im Vergleich zum Markt

PetVivo Holdings Dividendenrendite im Vergleich zum Markt

Wie sieht die Dividendenrendite von PETV im Vergleich zum Markt aus?
Segment	Dividendenrendite
Unternehmen (PETV)	n/a
Untere 25 % des Marktes (US)	1.4%
Markt Top 25 % (US)	4.2%
Branchendurchschnitt (Medical Equipment)	1.6%
Analystenprognose (PETV) (bis zu 3 Jahre)	n/a

Bemerkenswerte Dividende: Es ist nicht möglich, die Dividendenrendite von PETV im Vergleich zu den unteren 25 % der Dividendenzahler zu bewerten, da das Unternehmen keine aktuellen Ausschüttungen gemeldet hat.

Hohe Dividende: Es ist nicht möglich, die Dividendenrendite von PETV im Vergleich zu den besten 25 % der Dividendenzahler zu bewerten, da das Unternehmen keine aktuellen Ausschüttungen gemeldet hat.

Gewinnausschüttung an die Aktionäre

Abdeckung der Erträge: Unzureichende Daten zur Berechnung der Ausschüttungsquote von PETV, um festzustellen, ob die Dividendenzahlungen durch die Gewinne gedeckt sind.

Barausschüttung an die Aktionäre

Cashflow-Deckung: Es ist nicht möglich, die Nachhaltigkeit der Dividende zu berechnen, da PETV keine Ausschüttungen gemeldet hat.

PetVivo Holdings Ausschüttungen und Rückkäufe

Zukünftiges Wachstum Kriterienprüfungen 0/6

Wichtige Informationen

Jüngste Updates zu Dividenden und Rückkäufen

Recent updates

PetVivo Holdings, Inc. Reiterates Revenue Guidance for the Year 2025

PetVivo Holdings, Inc. to Report Q2, 2025 Results on Nov 14, 2024

PetVivo Holdings, Inc. Appoints Mike Eldred as Member of Board

Nasdaq Files Form 25 to Delist Securities of PetVivo Holdings

The Nasdaq Stock Market to Delist Common Stock of PetVivo Holdings

PetVivo Holdings, Inc. Reiterates Revenue Guidance for the Full Year 2025

PetVivo Holdings, Inc. to Report Q1, 2025 Results on Aug 14, 2024

PetVivo Holdings Receives a Non-Compliance Letter from the Nasdaq Stock Market

PetVivo Holdings, Inc. announced that it has received $1.21 million in funding

PetVivo Holdings, Inc. to Report Q4, 2024 Results on Jun 28, 2024

PetVivo Holdings, Inc.(OTCPK:PETV) dropped from S&P TMI Index

PetVivo Holdings Receives Determination Letter from the Nasdaq Hearings Panel Due to Failure to Regain Compliance with the Nasdaq Listing Rule 5550(b) by April 1, 2024

PetVivo Holdings, Inc.(OTCPK:PETV) dropped from NASDAQ Composite Index

Petvivo Holdings, Inc. Appoints Garry Lowenthal as Its New Chief Financial Officer

PetVivo Holdings, Inc. has completed a Follow-on Equity Offering in the amount of $0.959033 million.

Third quarter 2024 earnings released: US$0.12 loss per share (vs US$0.23 loss in 3Q 2023)

PetVivo Holdings, Inc. to Report Q3, 2024 Results on Feb 12, 2024

PetVivo Holdings, Inc. Announces Release of Clinical Study Results Involving Canine Tolerance to Intra-Articular Injections of Spryng with OsteoCushion Technology

Petvivo Receives Notice of Allowance from United States Patent and Trademark Office for Key Patent Application

PetVivo Holdings Receives Written Notice from Nasdaq Regarding Non-Compliance with the Minimum Stockholders’ Equity Requirement Under Nasdaq Listing Rule 5550(b)(1)

New major risk - Market cap size

PetVivo Holdings, Inc. Approves Election of Diane Levitan as Member of the Board

New major risk - Financial position

Second quarter 2024 earnings released: US$0.28 loss per share (vs US$0.21 loss in 2Q 2023)

PetVivo Holdings, Inc. to Report Q2, 2024 Results on Nov 14, 2023

PetVivo Holdings, Inc., Annual General Meeting, Nov 17, 2023

Independent Chairman of the Board recently bought US$51k worth of stock

PetVivo Receives Notice of Allowance from United States Patent and Trademark Office for Key Patent Application

First quarter 2024 earnings released: US$0.25 loss per share (vs US$0.20 loss in 1Q 2023)

PetVivo Holdings, Inc. to Report Q1, 2024 Results on Aug 10, 2023

New minor risk - Share price stability

Full year 2023 earnings: EPS and revenues miss analyst expectations

PetVivo Holdings, Inc. to Report Fiscal Year 2023 Results on Jun 29, 2023

PetVivo Holdings, Inc. Begins Process to Pursue Approval of Biomatrix Particulate Technology for Initial Human Indication

Third quarter 2023 earnings released: US$0.23 loss per share (vs US$0.17 loss in 3Q 2022)

PetVivo Holdings, Inc. to Report Q3, 2023 Results on Feb 09, 2023

Second quarter 2023 earnings: EPS exceeds analyst expectations while revenues lag behind

Second quarter 2023 earnings: EPS exceeds analyst expectations while revenues lag behind

Companies Like PetVivo Holdings (NASDAQ:PETV) Could Be Quite Risky

PetVivo Holdings, Inc. to Report Q2, 2023 Results on Nov 10, 2022

Petvivo Holding, Inc. Announces Spryng™ Now Available to Veternarians Through Mwi Animal Health

PetVivo Holdings, Inc., Annual General Meeting, Oct 14, 2022

First quarter 2023 earnings: EPS exceeds analyst expectations while revenues lag behind

PetVivo Holdings, Inc. to Report Q1, 2023 Results on Aug 11, 2022

PetVivo Holdings, Inc. Announces Board Appointments

Will PetVivo Holdings (NASDAQ:PETV) Spend Its Cash Wisely?

PetVivo Holdings GAAP EPS of -$0.57 beats by $0.37, revenue of $0.1M misses by $1.6M

Full year 2022 earnings: EPS and revenues miss analyst expectations

PetVivo Holdings, Inc. to Report Fiscal Year 2022 Results on Jun 29, 2022

We Think PetVivo Holdings (NASDAQ:PETV) Can Afford To Drive Business Growth

Third quarter 2022 earnings: EPS exceeds analyst expectations while revenues lag behind

PetVivo Holdings, Inc. to Report Q3, 2022 Results on Feb 10, 2022

Second quarter 2022 earnings released: US$0.13 loss per share (vs US$0.23 loss in 2Q 2021)

First quarter 2022 earnings released: US$0.071 loss per share (vs US$0.14 loss in 1Q 2021)

PetVivo Holdings Common Stock Deleted from Other OTC

High number of new directors

Petvivo Holdings, Inc. Enters into University Services Agreement with Colorado State University

PetVivo Holdings, Inc. announced that it has received $0.6 million in funding from RedDiamond Partners LLC

Petvivo Holdings, Inc. Appoints Dr. David B. Masters as Director of Science and Technology

Stabilität und Wachstum des Zahlungsverkehrs

Dividendenrendite im Vergleich zum Markt

Gewinnausschüttung an die Aktionäre

Barausschüttung an die Aktionäre

Entdecken Sie dividendenstarke Unternehmen